Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-16-012867
Filing Date
2016-10-07
Accepted
2016-10-07 15:42:42
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A stlt_10qa.htm 10-Q/A 376980
2 CERTIFICATION stlt_ex311.htm EX-31.1 10418
3 CERTIFICATION stlt_ex312.htm EX-31.2 10400
4 CERTIFICATION stlt_ex321.htm EX-32.1 3888
  Complete submission text file 0001477932-16-012867.txt   2383891

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT stlt-20160630.xml EX-101.INS 435459
6 XBRL TAXONOMY EXTENSION SCHEMA stlt-20160630.xsd EX-101.SCH 32876
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stlt-20160630_cal.xml EX-101.CAL 41259
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stlt-20160630_def.xml EX-101.DEF 92993
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE stlt-20160630_lab.xml EX-101.LAB 181066
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stlt-20160630_pre.xml EX-101.PRE 153190
Mailing Address 6750 WESTOWN PARKWAY SUITE 200-226 WEST DES MOINES IA 50266
Business Address 6750 WESTOWN PARKWAY SUITE 200-226 WEST DES MOINES IA 50266 515-274-9087
Spotlight Innovation, Inc. (Filer) CIK: 0001388486 (see all company filings)

EIN.: 980518266 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-52542 | Film No.: 161927658
SIC: 2834 Pharmaceutical Preparations